Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
NCT00003326 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2008-07-24
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with metastatic, recurrent, or unresectable cancer of the esophagus.
Conditions
- Esophageal Cancer
Interventions
- DRUG
Sponsors & Collaborators
-
Theradex
lead INDUSTRY
Principal Investigators
-
David Paul Kelsen, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-09-30
Countries
- United States
Study Locations
More Related Trials
-
Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
NCT00238407 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma
NCT02133612 ·Status: COMPLETED ·Phase: PHASE2
-
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
NCT00109850 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
NCT00003087 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
NCT02033538 ·Status: WITHDRAWN ·Phase: PHASE2
-
Radiation Dose Escalation in Esophageal Cancer
NCT03082586 ·Status: COMPLETED ·Phase: NA
-
Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer
NCT02530437 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
NCT00453323 ·Status: UNKNOWN ·Phase: PHASE2
-
PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
NCT00016900 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
NCT00072033 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
NCT00069953 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
NCT02392377 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
NCT00383266 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma
NCT00816634 ·Status: UNKNOWN ·Phase: PHASE2
-
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
NCT00033657 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
NCT00037089 ·Status: UNKNOWN ·Phase: PHASE2
-
TaxXel: Taxotere and Xeloda in Esophageal Cancer
NCT00821912 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer
NCT00601692 ·Status: COMPLETED ·Phase: PHASE1
-
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
NCT00008047 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
NCT00021320 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
NCT02762474 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
NCT00208936 ·Status: TERMINATED ·Phase: PHASE2
-
Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma
NCT00430027 ·Status: TERMINATED ·Phase: NA
-
Neoadjuvant Immunotherapy to ESCC
NCT04625543 ·Status: WITHDRAWN ·Phase: PHASE2